These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 10869476)
1. Evidence for the involvement of bone morphogenetic protein-2 in phenytoin-stimulated osteocalcin secretion in human bone cells. Koyama H; Nakade O; Saitoh T; Takuma T; Kaku T Arch Oral Biol; 2000 Aug; 45(8):647-55. PubMed ID: 10869476 [TBL] [Abstract][Full Text] [Related]
2. Osteogenic actions of phenytoin in human bone cells are mediated in part by TGF-beta 1. Nakade O; Baylink DJ; Lau KH J Bone Miner Res; 1996 Dec; 11(12):1880-8. PubMed ID: 8970889 [TBL] [Abstract][Full Text] [Related]
3. Effect of extracellular calcium on the gene expression of bone morphogenetic protein-2 and -4 of normal human bone cells. Nakade O; Takahashi K; Takuma T; Aoki T; Kaku T J Bone Miner Metab; 2001; 19(1):13-9. PubMed ID: 11156467 [TBL] [Abstract][Full Text] [Related]
4. Bone morphogenetic protein-2 and -4 (BMP-2 and -4) mediates fraxetin-induced maturation and differentiation in human osteoblast-like cell lines. Kuo PL; Huang YT; Chang CH; Chang JK Biol Pharm Bull; 2006 Jan; 29(1):119-24. PubMed ID: 16394523 [TBL] [Abstract][Full Text] [Related]
5. Follistatin restricts bone morphogenetic protein (BMP)-2 action on the differentiation of osteoblasts in fetal rat mandibular cells. Abe Y; Abe T; Aida Y; Hara Y; Maeda K J Bone Miner Res; 2004 Aug; 19(8):1302-7. PubMed ID: 15231018 [TBL] [Abstract][Full Text] [Related]
6. Role of activator protein 1 transcriptional activity in the regulation of gene expression by transforming growth factor beta1 and bone morphogenetic protein 2 in ROS 17/2.8 osteoblast-like cells. Palcy S; Bolivar I; Goltzman D J Bone Miner Res; 2000 Dec; 15(12):2352-61. PubMed ID: 11127200 [TBL] [Abstract][Full Text] [Related]
7. Piceatannol stimulates osteoblast differentiation that may be mediated by increased bone morphogenetic protein-2 production. Chang JK; Hsu YL; Teng IC; Kuo PL Eur J Pharmacol; 2006 Dec; 551(1-3):1-9. PubMed ID: 17026990 [TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures. Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of BMP-2 stimulated adhesion of osteoblastic cells to titanium alloy. Shah AK; Lazatin J; Sinha RK; Lennox T; Hickok NJ; Tuan RS Biol Cell; 1999 Mar; 91(2):131-42. PubMed ID: 10399828 [TBL] [Abstract][Full Text] [Related]
10. Participation of endogenous IGF-I and TGF-beta 1 with enamel matrix derivative-stimulated cell growth in human periodontal ligament cells. Okubo K; Kobayashi M; Takiguchi T; Takada T; Ohazama A; Okamatsu Y; Hasegawa K J Periodontal Res; 2003 Feb; 38(1):1-9. PubMed ID: 12558931 [TBL] [Abstract][Full Text] [Related]
11. Shedding of a soluble form of BMP receptor-IB controls bone cell responses to BMP. Singhatanadgit W; Salih V; Olsen I Bone; 2006 Nov; 39(5):1008-1017. PubMed ID: 16774854 [TBL] [Abstract][Full Text] [Related]
12. Myricetin induces human osteoblast differentiation through bone morphogenetic protein-2/p38 mitogen-activated protein kinase pathway. Hsu YL; Chang JK; Tsai CH; Chien TT; Kuo PL Biochem Pharmacol; 2007 Feb; 73(4):504-14. PubMed ID: 17113042 [TBL] [Abstract][Full Text] [Related]
13. The effect of bone morphogenetic protein-7 on the expression of type I inositol 1,4,5-trisphosphate receptor in G-292 osteosarcoma cells and primary osteoblast cultures. Bradford PG; Maglich JM; Ponticelli AS; Kirkwood KL Arch Oral Biol; 2000 Feb; 45(2):159-66. PubMed ID: 10716620 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts. Tang CH; Yang RS; Chien MY; Chen CC; Fu WM Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360 [TBL] [Abstract][Full Text] [Related]
15. Serial passage of MC3T3-E1 cells alters osteoblastic function and responsiveness to transforming growth factor-beta1 and bone morphogenetic protein-2. Chung CY; Iida-Klein A; Wyatt LE; Rudkin GH; Ishida K; Yamaguchi DT; Miller TA Biochem Biophys Res Commun; 1999 Nov; 265(1):246-51. PubMed ID: 10548521 [TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. Katagiri T; Yamaguchi A; Komaki M; Abe E; Takahashi N; Ikeda T; Rosen V; Wozney JM; Fujisawa-Sehara A; Suda T J Cell Biol; 1994 Dec; 127(6 Pt 1):1755-66. PubMed ID: 7798324 [TBL] [Abstract][Full Text] [Related]
17. Phenytoin at micromolar concentrations is an osteogenic agent for human-mandible-derived bone cells in vitro. Nakade O; Baylink DJ; Lau KH J Dent Res; 1995 Jan; 74(1):331-7. PubMed ID: 7876426 [TBL] [Abstract][Full Text] [Related]
18. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687 [TBL] [Abstract][Full Text] [Related]
19. Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2. Lecanda F; Avioli LV; Cheng SL J Cell Biochem; 1997 Dec; 67(3):386-96. PubMed ID: 9361193 [TBL] [Abstract][Full Text] [Related]
20. Alphavbeta integrins play an essential role in BMP-2 induction of osteoblast differentiation. Lai CF; Cheng SL J Bone Miner Res; 2005 Feb; 20(2):330-40. PubMed ID: 15647827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]